Organisation paid for research Program year 2025 Source: CMS Open Payments

Velocity Clinical Research - Hampton

Neither a doctor nor a teaching hospital

Research payments

$51,654

4 payments

Through program year 2025, Velocity Clinical Research - Hampton is reported as receiving $51,654 in research payments, across 4 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2025	Research	$41,724	3
2023	Research	$9,930	1

Breakdown

Who paid Research payments · program years 2023–2025

Merck Sharp & Dohme Corporation $51,654 4 payments

Studies the money was for Research payments · program years 2023–2025

A Phase 3, Randomized, Placebo-Controlled, Double Blind Clinical Study to Evaluate the Efficacy and Safety of Molnupiravir MK-4482 in Non-Hospitalized Adults with COVID-19 at High Risk for Disease Progression $23,760 1 payment
A Phase 3, Randomized, Placebo-Controlled, Double Blind Clinical Study to Evaluate the Efficacy and Safety of Molnupiravir MK-4482 in Non-Hospitalized Adults with COVID-19 at High Risk for Disease Progression $15,000 1 payment
A Phase 3, Randomized, Placebo-Controlled, Double Blind Clinical Study to Evaluate the Efficacy and Safety of MK-4482 in Non-Hospitalized Adults with COVID-19 at High Risk for Disease Progression $9,930 1 payment
A Phase 3, Randomized, Placebo-Controlled, Double Blind Clinical Study to Evaluate the Efficacy and Safety of Molnupiravir MK-4482 in Non-Hospitalized Adults with COVID-19 at High Risk for Disease Progression $2,964 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.